Chronic myeloid leukaemia accounted for less than 1% of all new cancer cases in the UK in 2016-2018.[1-4]
In females in the UK, chronic myeloid leukaemia accounted for less than 1% of all new female cancer cases. In males in the UK, it accounted for less than 1% of all new male cancer cases).
45% of chronic myeloid leukaemia cases in the UK are in females, and 55% are in males.
Chronic myeloid leukaemia incidence rates (European age-standardised
For chronic myeloid leukaemia, there are few established risk factors therefore differences between countries largely reflect differences in diagnosis and data recording.
Chronic Myeloid Leukaemia (C92.1), Average Number of New Cases Per Year, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2016-2018
|AS Rate - 95% LCL||1.1||0.9||0.7||0.5||1.1|
|AS Rate - 95% UCL||1.2||1.3||1.3||1.2||1.2|
|AS Rate - 95% LCL||1.5||1.2||0.8||1.1||1.5|
|AS Rate - 95% UCL||1.7||1.7||1.4||2.1||1.6|
|AS Rate - 95% LCL||1.3||1.1||0.8||0.9||1.3|
|AS Rate - 95% UCL||1.4||1.4||1.2||1.5||1.4|
Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, July 2021. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
Data were provided by ISD Scotland on request, April 2020. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
Data were published by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-incidence-in-wales-2002-2018/, March 2021.
Data were provided by the Northern Ireland Cancer Registry on request, May 2020. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
About this data
Data is for UK, 2016-2018, ICD-10 C92.1.